Zydus Animal Health Limited completed the acquisition of Select Brands and Manufacturing Opertaions In Haridwar from Zoetis Inc..

Zydus Animal Health Limited signed an agreement to acquire Select Brands and Manufacturing Opertaions In Haridwar from Zoetis Inc. (NYSE:ZTS) for $29 million on January 5, 2016. The agreement also provides for the divestment by Zoetis of a portfolio of generic products which are associated with the Haridwar site. These products include medicated feed additives, anti-infectives, parasiticides, and nutritionals for livestock sold primarily in India. The Board of Directors of Cadila Healthcare Limited approved the transaction. The transaction is expected to complete in the first quarter of 2016. Nandish Vyas, Tushar Raut and Rebha Dakshini of Veritas Legal acted as legal advisor for Zoetis Inc. Charles Hoare, Felix Alexander Siek, Irina Konovalova and David Rumpf of Commerzbank AG (DB:CBK) acted as financial advisor for Zoetis Inc.


Zydus Animal Health Limited completed the acquisition of Select Brands and Manufacturing Opertaions In Haridwar from Zoetis Inc. (NYSE:ZTS) in January 2016.